⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NUVB News
Nuvation Bio Inc.
Nuvation Bio to Participate in Upcoming Investor Conferences
prnewswire.com
NUVB
Form 8-K
sec.gov
NUVB
Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
NUVB
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
prnewswire.com
NUVB
Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
prnewswire.com
NUVB
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
globenewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nuvation Bio Inc. (NUVB) And Encourages Shareholders to Reach Out
accessnewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nuvation Bio Inc. (NUVB) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
NUVB
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc. (NUVB) Shareholders to Inquire about Securities Investigation
accessnewswire.com
NUVB